Thyroid carcinoma is the most common endocrine malignancy, and its incidence is
continuing to increase. Most thyroid carcinomas contain one of several known driver …

Thyroid nodules are common, and the accurate diagnosis of cancer or benign disease is
important for the effective clinical management of patients. Molecular markers are a helpful …

Anaplastic thyroid carcinoma (ATC) has among the worst prognoses of any solid
malignancy. The low incidence of the disease has in part precluded systematic clinical trials …

MicroRNAs (miRNAs) have emerged as a class of powerful gene expression regulators.
Acting at the post-transcriptional level, miRNAs modulate the expression of at least one-third …

Differentiated thyroid cancer (DTC) is the most common endocrinological malignancy. There
are several histological variants such as papillary and follicular thyroid carcinoma. Many …

The role of p53 as the “guardian of the genome” in differentiated somatic cells, triggering
various biological processes, is well established. Recent studies in the stem cell field have …

It is well accepted that expression of mutant p53 involves the gain of oncogenic-specific
activities accentuating the malignant phenotype. Depending on the specific cancer type …

Anaplastic thyroid cancer (ATC) is among the most lethal types of cancers, characterized as
a fast‐growing and highly invasive thyroid tumor that is unresponsive to surgery and …

Thyroid carcinoma is the most common endocrine malignancy, and although the disease
generally has an excellent prognosis, therapeutic options are limited for patients not cured …

Anaplastic thyroid cancer (ATC), accounting for less than 2% of all thyroid cancer, is
responsible for the majority of death from all thyroid malignancies and has a median survival …